NCT07367620

Brief Summary

The goal of this observational study is to determine the incidence of immediate mechanical complications after central venous catheterization and to explore factors associated with major mechanical complications in adolescent and adult patients undergoing central venous catheter insertion in routine clinical care. The main questions it aims to answer are: What is the incidence of immediate mechanical complications, including major complications, following central venous catheterization? Which patient-, operator-, and procedure-related factors are associated with major mechanical complications? To what extent can these factors be combined to estimate the risk of major mechanical complications before catheter insertion? This study builds on a previous multicentre registry study of central venous catheterization but includes a substantially larger number of catheter insertions. An additional exploratory objective is to assess the feasibility of developing a risk estimation model (CATH-RISK) for major mechanical complications based on available data. Participants will have their central venous catheter insertions and related clinical data recorded in an existing clinical registry. No interventions beyond standard clinical care will be performed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
29,114

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2019

Completed
6.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 16, 2025

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

January 17, 2026

Completed
9 days until next milestone

First Posted

Study publicly available on registry

January 26, 2026

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 17, 2026

Completed
Last Updated

April 28, 2026

Status Verified

April 1, 2026

Enrollment Period

6.5 years

First QC Date

January 17, 2026

Last Update Submit

April 27, 2026

Conditions

Keywords

central venous cathetersCatheterization, Central VenousVascular Access Devices

Outcome Measures

Primary Outcomes (4)

  • Number of cases with bleeding grade 3-4

    Mechanical complication after CVC-insertion. Grade 3 bleedings/hematoma formation/hemothorax (bleedings requiring invasive intervention or blood transfusion) or arterial catheter placement and grade 4 bleedings/hemothorax (life-threatening bleedings). All grade 3-4 bleedings will be classified as major mechanical complications.

    Up to 24 hours after insertion of the central venous catheter

  • Number of cases with arrhythmia grad 3-4 during the inserting procedure

    Mechanical complication during the CVC-insertion. Recognized at the continuous ECG by the inserting physician or the assistant. Arrhythmias grade 3 (symptomatic arrhythmia requiring urgent medical intervention) and grade 4 (symptomatic arrhythmia with life-threatening consequences) will be considered major mechanical complications.

    During the procedure of inserting the central venous catheter

  • Number of cases with pneumothorax at post-procedural x-ray of the thorax

    Mechanical complication after CVC-insertion. Pneumothoraces will be detected using x-ray after the central venous catheter insertion. All pneumothoraces will be classified as major mechanical complications

    Up to 24 hours after insertion of the central venous catheter

  • Number of cases with persistent nerve injury classified as sensory loss, paraesthesia or loss of motor neuron function

    Mechanical complication after CVC-insertion. Will be detected and documented by the patient responsible physician or nurse. Will be considered a major mechanical complication.

    Persistent more than 72 hours after insertion of the central venous catheter

Secondary Outcomes (4)

  • Number of cases with failure to place the catheter

    During the procedure of inserting the central venous catheter

  • Number of cases with bleeding grad 2

    Up to 24 hours after insertion of the central venous catheter

  • Number of cases with arrhythmia grad 1-2 during the inserting procedure

    During the procedure of inserting the central venous catheter

  • Number of cases with transient nerve injury classified as sensory loss, paraesthesia or loss of motor neuron function

    Transient up to 72 hours after insertion of the central venous catheter

Study Arms (1)

Patients undergoing central venous catheterization

This cohort includes adolescent and adult patients undergoing central venous catheter insertion as part of routine clinical care at participating hospitals. Catheterizations are performed according to local clinical guidelines and standard practice, predominantly using real-time ultrasound guidance. No study-specific interventions are mandated. Data on patient characteristics, operator factors, procedural details, and immediate mechanical complications occurring after catheter insertion are collected from existing electronic health record-based registries. The study is purely observational and does not influence clinical decision-making, choice of catheterization technique, or patient management.

Device: Central Venous Catheterization

Interventions

No intervention is assigned in this study. Central venous catheter insertions are performed according to standard clinical practice and local guidelines at participating hospitals. The study involves observational data collection only, using information routinely documented in the electronic health record and clinical registries. No changes to patient management, catheterization technique, or follow-up are introduced as part of the study.

Patients undergoing central venous catheterization

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients receiving a central venous catheter within the study period will be observed

You may qualify if:

  • All patients receiving a central venous catheter within the study period will be observed

You may not qualify if:

  • Patients who die within 24 hours for reasons unrelated to the catheterization will be excluded, whereas patients whose death is directly related to the central venous catheterization will be included

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Region Skåne

Lund, Skåne County, Sweden

Location

MeSH Terms

Interventions

Catheterization, Central Venous

Intervention Hierarchy (Ancestors)

CatheterizationTherapeuticsEndovascular ProceduresVascular Surgical ProceduresCardiovascular Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical ProceduresInvestigative Techniques

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 17, 2026

First Posted

January 26, 2026

Study Start

March 1, 2019

Primary Completion

August 16, 2025

Study Completion

April 17, 2026

Last Updated

April 28, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share

Individual participant data collected in this study will not be made publicly available. De-identified data may be shared with qualified researchers upon reasonable request, subject to approval by the study steering committee and applicable ethical and legal regulations. Requests should include a methodologically sound research proposal and may require a data use agreement.

Shared Documents
CSR
Time Frame
Data will be available beginning after publication of the primary study results, with no defined end date
Access Criteria
De-identified individual participant data may be shared with qualified researchers upon reasonable request and approval by PI, in accordance with ethical and data protection regulations. Data will be shared via secure transfer after execution of a data use agreement

Locations